OPTR Insider Trading Activity and SEC Form 4 Filings
OPTR insider trading summary
No open-market insider purchases or sales of Optimer Pharmaceuticals Inc (OPTR) have been reported on SEC Form 4 in the past 12 months.
Latest OPTR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 8, 2013 | Pedro Lichtinger | Insider | Sell | $1.3M (90,000 @ $14.73) |
| Apr 8, 2013 | Pedro Lichtinger | Insider | Sell | $848K (58,000 @ $14.63) |
| Nov 8, 2012 | Pedro Lichtinger | CEO and President | Buy | $100K (11,000 @ $9.08) |
| Jun 11, 2012 | Joseph Y Chang | Director | Sell | $53K (3,461 @ $15.30) |
| Aug 9, 2011 | Anthony E Altig | Director | Buy | $37K (5,000 @ $7.44) |
| Aug 4, 2011 | Pedro Lichtinger | CEO and President | Buy | $224K (25,000 @ $8.98) |
| May 12, 2010 | Joseph Y Chang | Director | Sell | $54K (4,615 @ $11.75) |
| May 12, 2010 | Joseph Y Chang | Director | Sell | $41K (3,461 @ $11.75) |
| Dec 29, 2009 | Michael N Chang | CEO and President | Buy | $86K (8,000 @ $10.80) |
| Dec 29, 2009 | Tessie M Che | COO and SVP | Buy | $86K (8,000 @ $10.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.